The activity of drug-metabolizing enzymes and the biotransformation of selected anthelmintics in the model tapeworm Hymenolepis diminuta

Parasitology

Volumn 139, Issue 6, 2012, Pages 809-818

  Bártíková, Hana ^a   Vokřál, Ivan ^a   Skálová, Lenka ^a   Kubíček, Vladimír ^a   Firbasová, Jana ^a   Briestenský, David ^a   Lamka, Jiří ^a   Szotáková, Barbora ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

albendazole; biotransformation enzymes; drug metabolism; flubendazole; liquid chromatography mass spectrometry; mebendazole

Indexed keywords

ALBENDAZOLE; CARBONYL DERIVATIVE; CATALASE; DRUG METABOLIZING ENZYME; FLUBENDAZOLE; GLUTATHIONE TRANSFERASE; MEBENDAZOLE; ORACIN; PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SUPEROXIDE DISMUTASE;

ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG METABOLISM; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME KINETICS; EX VIVO STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYMENOLEPIS DIMINUTA; IN VITRO STUDY; MALE; MASS SPECTROMETRY; MITOCHONDRION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SPECTROFLUOROMETRY;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; GLUTATHIONE TRANSFERASE; HYMENOLEPIASIS; HYMENOLEPIS DIMINUTA; MASS SPECTROMETRY; MEBENDAZOLE; OXIDATION-REDUCTION; RATS;

CESTODA; HYMENOLEPIS DIMINUTA; MONIEZIA; VERMES;

EID: 84861063427     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182011002265     Document Type: Article

References (51)

1. Barrett, J. (1997). Helminth detoxification mechanisms. Journal of Helminthology 71, 85-89.
2. Barrett, J. (1998). Cytochrome P450 in parasitic protozoa and helminths. Comparative Biochemistry and Physiology 121, 181-183.
3. Bartikova, H., Krizova, V., Lamka, J., Kubicek, V., Skalova, L. and Szotakova, B. (2010a). Flubendazole metabolism and biotransformation enzymes activities in healthy sheep and sheep with haemonchosis. Journal of Veteterinary Pharmacology and Therapeutics 33, 56-62.
4. Bartikova, H., Vokral, I., Skalova, L., Lamka, J. and Szotakova, B. (2010b). In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo. Xenobiotica 40, 593-601.
5. Budke, C. M., Deplazes, P. and Torgerson, P. R. (2006). Global socioeconomic impact of cystic echinococcosis. Emerging Infectious diseases 12, 296-303.
6. Cohen, R. and Mackey, K. (1977). Hymenolepis diminuta unresponsive to quinacrine. The Western Journal of Medicine 127, 340-341.
7. Cunningham, L. J. and Olson, P. D. (2010). Description of Hymenolepis microstoma (Nottingham strain): a classical tapeworm model for research in the genomic era. Parasites & Vectors 3, 123.
8. Cvilink, V., Kubicek, V., Nobilis, M., Krizova, V., Szotakova, B., Lamka, J., Varady, M., Kubenova, M., Novotna, R., Gavelova, M. and Skálová, L. (2008a). Biotransformation of flubendazole and selected model xenobiotics in Haemonchus contortus. Veterinary Parasitology 151, 242-248.
9. Cvilink, V., Lamka, J. and Skalova, L. (2009a). Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths. Drug Metabolism Reviews 41, 8-26.
10. Cvilink, V., Skalova, L., Szotakova, B., Lamka, J., Kostiainen, R. and Ketola, R. A. (2008b). LC-MS-MS identification of albendazole and flubendazole metabolites formed ex vivo by Haemonchus contortus. Analytical and Bioanalytical Chemistry 391, 337-343.
11. Cvilink, V., Szotakova, B., Krizova, V., Lamka, J. and Skalova, L. (2009b). Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum). Research in Veterinary Science 86, 49-55.
12. Cvilink, V., Szotakova, B., Vokral, I., Bartikova, H., Lamka, J. and Skalova, L. (2009c). Liquid chromatography/mass spectrometric identification of benzimidazole anthelminthics metabolites formed ex vivo by Dicrocoelium dendriticum. Rapid Communications in Mass Spectrometry 23, 2679-2684.
13. Habig, W. H. and Jakoby, W. B. (1981). Glutathione S-transferases (rat and human). Methods in Enzymology 77, 218-231.
14. Henkle-Duhrsen, K. and Kampkotter, A. (2001). Antioxidant enzyme families in parasitic nematodes. Molecular and Biochemical Parasitology 114, 129-142.
15. Hitchen, S. J., Shostak, A.W. and Belosevic, M. (2009). Hymenolepis diminuta (Cestoda) induces changes in expression of select genes of Tribolium confusum (Coleoptera). Parasitology Research 105, 875-879.
16. Horak, P. and Klimes, L. (2007). Helmintologie. In Paraziti a Jejich Biologie (ed. Volf, P. and Horák, P.), pp. 138-231. Triton, Praha, Czech Republic.
17. Hussain, M., Khan, I., Siddiqui, M., Farooq, M. and Ahmad, N. (2004). Prevalence of cestodes and comparative efficacy of various anthelmintics in Rambouillet sheep. International Journal of Agriculture and Biology 6, 1128-1131.
18. Jones, W. E. (1979). Niclosamide as a treatment for Hymenolepis diminuta and Dipylidium caninum infection in man. The American Journal of Tropical Medicine and Hygiene 28, 300-302.
19. Kerboeuf, D., Soubieux, D., Guilluy, R., Brazier, J. L. and Riviere, J. L. (1995). In vivo metabolism of aminopyrine by the larvae of the helminth Heligmosomoides polygyrus. Parasitology Research 81, 302-304.
20. Kotze, A. C. (1997). Cytochrome P450 monooxygenase activity in Haemonchus contortus (Nematoda). International Journal for Parasitology 27, 33-40.
21. Kotze, A. C., Dobson, R. J. and Chandler, D. (2006). Synergism of rotenone by piperonyl butoxide in Haemonchus contortus and Trichostrongylus colubriformis in vitro: potential for drug-synergism through inhibition of nematode oxidative detoxification pathways. Veterinary Parasitology 136, 275-282.
22. Kuntz, A. N., Davioud-Charvet, E., Sayed, A. A., Califf, L. L., Dessolin, J., Arner, E. S. J. and Williams, D. L. (2007). Thioredoxin glutathione reductase from Schistosoma mansoni: An essential parasite enzyme and a key drug target. PLoS Medicine 4, 1071-1086.
23. Maki, J. and Yanagisawa, T. (1985). Anthelmintic effects of bithionol, paromomycin sulphate, flubendazole and mebendazole on mature and immature Hymenolepis nana in mice. Journal of Helminthology 59, 211-216.
24. Marangi, M., Zechini, B., Fileti, A., Quaranta, G. and Aceti, A. (2003). Hymenolepis diminuta infection in a child living in the urban area of Rome, Italy. Journal of Clinical Microbiology 41, 3994-3995.
25. Maser, E. (1995). Xenobiotic carbonyl reduction and physiological steroid oxidoreduction - the pluripotency of several hydroxysteroid dehydrogenases. Biochemical Pharmacology 49, 421-440.
26. Maté, L., Virkel, G., Lifschitz, A., Ballent, M. and Lanusse, C. (2008). Hepatic and extrahepatic metabolic pathways involved in flubendazole biotransformation in sheep. Biochemical Pharmacology 76, 773-783.
27. Matossian, R. M., Rickard,M. D. and Smyth, J. D. (1977). Hydatidosis: a global problem of increasing importance. Bulletin of the World Health Organization 55, 499-507.
28. McCracken, R. O. and Taylor, D. D. (1983). Biochemical effects of thiabendazole and cambendazole on Hymenolepis diminuta (Cestoda) in vivo. Journal of Parasitology 69, 295-301.
29. McCracken, R. O., Lipkowitz, K. B. and Dronen, N. O. (1992). Efficacy of albendazole and mebendazole against Hymenolepis microstoma and Hymenolepis diminuta. Parasitology Research 78, 108-111.
30. Mizuma, T., Machida, M., Hayashi, M. and Awazu, S. (1982). Correlation of drug conjugative metabolism rates between in vivo and in vitro: glucuronidation and sulfation of p-nitrophenol as a model compound in rat. Journal of Pharmacobio-Dynamics 5, 811-817.
31. Moreno, L., Alvarez, L., Mottier, L., Virkel, G., Bruni, S. S. and Lanusse, C. (2004). Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability. Journal of Veteterinary Pharmacology and Therapeutics 27, 299-308.
32. Moro, P. L., Budke, C. M., Schantz, P. M., Vasquez, J., Santivanez, S. J. and Villavicencio, J. (2011). Economic impact of cystic echinococcosis in Peru. PLoS Neglected Tropical Diseases 5 (5), e1179.
33. Muller, R. and Wakelin, D. (2002). The cestodes. In Worms and Human Disease (ed. Muller, R.), pp. 63-105. CABI Publishing, New York, USA.
34. Munir, W. A. and Barrett, J. (1985). The metabolism of xenobiotic compounds by Hymenolepis diminuta (Cestoda: Cyclophyllidea). Parasitology 91, 145-156.
35. Ohara, H., Miyabe, Y., Deyashiki, Y., Matsuura, K. and Hara, A. (1995). Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochemical Pharmacology 50, 221-227.
36. Ostlind, D. A., Mickle, W. G., Smith, S. K., Cifelli, S. and Ewanciw, D. V. (2004). The Hymenolepis diminuta-golden hamster (Mesocricetus auratus) model for the evaluation of gastrointestinal anticestode activity. Journal of Parasitology 90, 898-899.
37. Palackal, N. T., Burczynski, M. E., Harvey, R. G. and Penning, T. M. (2001). Metabolic activation of polycyclic aromatic hydrocarbon transdihydrodiols by ubiquitously expressed aldehyde reductase (AKR1A1). Chemico-Biological Interactions 130-132, 815-824.
38. Robinson, M.W., Lawson, J., Trudgett, A., Hoey, E. M. and Fairweather, I. (2004). The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitology Research 92, 205-210.
39. Rossjohn, J., Feil, S. C., Wilce, M. C., Sexton, J. L., Spithill, T.W. and Parker, M.W. (1997). Crystallization, structural determination and analysis of a novel parasite vaccine candidate: Fasciola hepatica glutathione S-transferase. Journal of Molecular Biology 273, 857-872.
40. Saeed, H. M., Mostafa, M. H., O'Connor, P. J., Rafferty, J. A. and Doenhoff,M. J. (2002). Evidence for the presence of active cytochrome P450 systems in Schistosoma mansoni and Schistosoma haematobium adult worms. FEBS Letters 519, 205-209.
41. Salinas, G., Selkirk, M. E., Chalar, C., Maizels, R. M. and Fernandez, C. (2004). Linked thioredoxin-glutathione systems in platyhelminths. Trends in Parasitology 20, 340-346.
42. Slocombe, J. O. D. (1979). Prevalence and treatment of tapeworms in horses. The Canadian Veterinary Journal 20, 136-140.
43. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J. and Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150, 76-85.
44. Solana, H. D., Rodriguez, J. A. and Lanusse, C. E. (2001). Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Parasitology Research 87, 275-280.
45. Szotakova, B., Skalova, L., Wsol, V. and Kvasnickova, E. (2000). Reduction of the potential anticancer drug oracin in the rat liver in vitro. Journal of Pharmacy and Pharmacology 52, 495-500.
46. Tanowitz, H. B., Weiss, L. M. and Wittner, M. (1993). Diagnosis and treatment of intestinal helminths. I. Common intestinal cestodes. Gastroenterologist 1, 265-273.
47. Webbe, G. (1994). Human cysticercosis: parasitology, pathology, clinical manifestations and available treatment. Pharmacology Therapeutics 64, 175-200.
48. White, A. C. (2000). Neurocysticercosis: Updates on epidemiology, pathogenesis, diagnosis, and management. Annual Review of Medicine 51, 187-206.
49. Wiwanitkit, V. (2004). Overview of Hymenolepis diminuta infection among Thai patients. Medscape General Medicine 6, 7.
50. Wsol, V., Szotakova, B., Martin, H. J. and Maser, E. (2007). Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man. Toxicology 238, 111-118.
51. Wsol, V., Szotakova, B., Skalova, L. and Maser, E. (2004). The novel anticancer drug oracin: different stereospecificity and cooperativity for carbonyl reduction by purified human liver 11beta-hydroxysteroid dehydrogenase type 1. Toxicology 197, 253-261.